Skip to main content
Back to Wellington Management

Wellington Management's Health Care Portfolio

Browse 58 Health Care companies funded by Wellington Management. See funding amounts, founder contacts, and investment details.

Health Care Companies
58
Total Funding in Health Care
$10.4B

Health Care Portfolio Companies (58)

Export
Health CareMedicalPharmaceutical

Judi Health is a healthtech platform that provides pharmacy benefit management solutions.

New York, United States
September 2025
$252.0M
Series F

Founder Contacts

30,000+ verified contacts

Health CareHealth InsuranceInsuranceInsurTech

Oscar is a health insurance company that offers individual and family plans, medicare advantages, and small group products.

New York, United States
September 2025
$355.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical DevicePharmaceutical

RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.

San Diego, United States
September 2022
$160.0M
Series D

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalNeurosciencePharmaceuticalTherapeutics

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Waltham, United States
September 2025
$150.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

San Diego, United States
September 2025
$690.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareInformation TechnologyMedicalmHealthTelehealth

Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs.

Los Angeles, United States
July 2022
$20.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceutical

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

South San Francisco, United States
July 2024
$175.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareHealth DiagnosticsMedical DeviceOncology

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

Ann Arbor, United States
July 2021
$90.0M
Series C

Founder Contacts

30,000+ verified contacts

ConsumerHealth CareInformation TechnologymHealth

Sharecare is a health and wellness engagement platform that provides information, programs, and resources to improve individuals health.

Atlanta, United States
July 2021
$425.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceOncologyPrecision Medicine

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

Boston, United States
July 2024
$150.0M
Series C

Founder Contacts

30,000+ verified contacts

Health CareSocialWellness

Cityblock Health is a tech-driven healthcare provider that offers comprehensive and personalised care for underserved communities.

Brooklyn, United States
July 2022
Secondary Market

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Waltham, United States
June 2023
$200.0M
Series B

Founder Contacts

30,000+ verified contacts

BioinformaticsBiotechnologyHealth CareMedical

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

Cambridge, United States
June 2022
$1.3B
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

New York, United States
June 2026
$250.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.

London, United Kingdom
June 2026
$112.5M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyEmergency MedicineGeneticsHealth CareMedical

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Boston, United States
June 2024
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

FitnessHealth CareWellnessWomen's

Caraway is providing college women+ with integrated mental, reproductive, and physical healthcare.

New York, United States
June 2023
$16.8M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Cambridge, United States
June 2026
$200.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Cambridge, United States
June 2026
$50.0M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalOncology

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Philadelphia, United States
May 2025
$40.2M
Series D

Founder Contacts

30,000+ verified contacts

Health CareMedicalTherapeuticsWellness

Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.

San Francisco, United States
May 2025
Secondary Market

Founder Contacts

30,000+ verified contacts

CyclingFitnessHealth CareWellness

Peloton is an interactive fitness platform reinventing fitness with live and on-demand boutique studio classes.

New York, United States
May 2024
$300.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceOncologyTherapeutics

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

La Jolla, United States
May 2023
$100.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Cambridge, United States
April 2024
$130.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Cambridge, United States
April 2024
$160.5M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CarePharmaceutical

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Waltham, United States
March 2026
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical

Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

Mountain View, United States
March 2025
$98.0M
Convertible Note

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth Care

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Cambridge, United States
March 2023
$76.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalTherapeutics

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Stevenage, United Kingdom
March 2022
$26.1M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareHealth DiagnosticsHospitalMedicalPrimary and Urgent CareWellness

Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups.

Mclean, United States
February 2022
$325.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Copenhagen, Denmark
February 2026
$275.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

Munich, Germany
October 2025
$400.6M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

Durham, United States
April 2025
$150.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

San Mateo, United States
January 2025
$65.0M
Series A

Founder Contacts

30,000+ verified contacts

Health Care

Mindset assists those with a mental illness and their caregivers in applying for Social Security Disability benefits.

New York, United States
August 2024
$13.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel, United States
August 2024
$63.5M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

San Mateo, United States
May 2024
$182.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareLife Science

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Cambridge, United States
January 2024
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)ElectronicsHealth CareManufacturingMedical DeviceSemiconductor

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

Burlington, United States
January 2025
$75.6M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

Rockville, United States
December 2025
$185.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Cambridge, United States
December 2025
$602.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareMedicalPharmaceutical

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

New York, United States
November 2024
$215.0M
Series B

Founder Contacts

30,000+ verified contacts

Health CareMedicalMedical DeviceNeuroscienceTherapeutics

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

Bloomington, United States
November 2025
$30.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

Waltham, United States
November 2025
$200.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyClinical TrialsHealth CareMedicalPharmaceuticalTherapeutics

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Hayward, United States
October 2025
$250.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

San Francisco, United States
October 2025
$250.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Watertown, United States
October 2025
$225.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Tricida operates in the healthcare industry focusing on pharmaceutical business.

Menlo Park, United States
October 2022
$125.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Westlake Village, United States
February 2026
$130.0M
Series D

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Boulder, United States
April 2025
$200.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.

Suzhou, China
August 2023
$100.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalOncology

NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.

Wilmington, United States
May 2021
$200.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.

South San Francisco, United States
March 2021
$80.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical Device

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Redwood City, United States
August 2020
$70.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareProduct ResearchTherapeutics

Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.

South San Francisco, United States
July 2020
$125.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsHealth CareOncology

Forty Seven is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways.

Palo Alto, United States
August 2019
$6.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BioinformaticsBiotechnologyHealth CareMedicalTherapeutics

NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.

Cambridge, United States
December 2017
$36.0M
Series B

Founder Contacts

30,000+ verified contacts

Developer PlatformHealth CarePharmaceutical

Rhythm Metabolic develops a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies.

Boston, United States
August 2015
$40.0M
Series A

Founder Contacts

30,000+ verified contacts

Explore Wellington Management's Full Portfolio

View all companies funded by Wellington Management across every industry and funding stage.

View Full Wellington Management Portfolio